VTYX (Ventyx Biosciences, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
Ventyx Biosciences, Inc. Common Stock (VTYX) is a publicly traded Healthcare sector company. As of May 21, 2026, VTYX trades at $14.00 with a market cap of $1.00B and a P/E ratio of -7.11. VTYX moved +0.07% today. Year to date, VTYX is +253.53%; over the trailing twelve months it is +872.22%. Its 52-week range spans $0.78 to $25.00. Analyst consensus is hold with an average price target of $14.00. Rallies surfaces VTYX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns VTYX stock?
Hedge funds tracked by Rallies that own VTYX include Orbimed Advisors and Redmile Group. The latest tracked quarter is Mar 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Ventyx Biosciences, Inc. Common Stock.
VTYX Key Metrics
Key financial metrics for VTYX
Metric
Value
Price
$14.00
Market Cap
$1.00B
P/E Ratio
-7.11
EPS
$-1.97
Dividend Yield
0.00%
52-Week High
$25.00
52-Week Low
$0.78
Volume
5.45M
Avg Volume
0
Revenue (TTM)
$0
Net Income
$-135.12M
Gross Margin
0.00%
Top Hedge Funds Holding VTYX
Orbimed Advisors holds 1.87M shares of VTYX, changed +0.00% as of Mar 31, 2024.
Redmile Group holds 1.07M shares of VTYX, changed -3.69% as of Sep 30, 2025.
Hedge funds tracked by Rallies that own VTYX include Orbimed Advisors and Redmile Group. The latest tracked quarter is Mar 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Ventyx Biosciences, Inc. Common Stock.
Does Rallies show 13F holders for VTYX?
Yes. Rallies tracks hedge fund and 13F ownership data for VTYX, including fund names, share counts, latest tracked quarter, and position changes when available.
Is VTYX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for VTYX. It does not provide personalized investment advice.